Journal for ImmunoTherapy of Cancer (2020-11-01)

409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO)

  • John Stewart,
  • Donna Niedzwiecki,
  • John Strickler,
  • Niharika Mettu,
  • Shannon MacLaughlan,
  • Edward Levine,
  • Daniel Blazer

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0409
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.